“…Colon cancer ↓ TNF-𝛼, IL-1𝛽, IL-6, NF-𝜅B, p-NF-𝜅B, COX-2, PCNA, and Cyclin D1 [ 104] RAW264.7 cells ↓ GP91 phosphorylation, p47 phosphorylation, JAKs, and STAT1 [ 106] Kaempferol Proliferation Ovarian cancer ↑ DR4, DR5, CHOP, JNK, ERK1/2, p38 [26] Gastric cancer ↓ NF-𝜅B and MAPK signaling pathways [27] Colon cancer ↓ CDK2, CDK4, cyclin A/D/E [28] Ovarian cancer ↑ p21, p-Chk2, p-Cdc25C, p-Cdc2 [29] Apigenin Proliferation Prostate cancer ↓ Rb, p-Rb (Ser807/811), phospho-Rb (Ser780), p-ELK-1, c-FOS, and cyclin D1; ↑ p-ERK1/2, p-JNK1/2 [41] Melanoma ↓ p-ERK1/2, p-AKT, and p-mTOR [43] Breast cancer ↑ cl-caspase-8, cl-caspase-3, and cl-PARP; ↓ p-JAK2 and p-STAT3 [40] Cervical cancer ↑ p16, INK4A; ↓ cyclin A/D/E and CDK2/6; ↓ the PTEN/PI3K/AKT pathway [42] Angiogenesis Esophageal cancer ↓ VEGF and IL-6 expression [91] Melanoma ↓ IL-6, IL-10 and TNF-ɑ [92] Immunity inflammation Colonic inflammation ↓MPO, inflammatory cytokines, and COX-2 [ 108] Pancreatic cancer ↓ SK-3𝛽/NF-𝜅B signaling pathway [10] NSCLC ↓ IFN-𝛾-induced PD-L1 expression [ 112] Hesperetin Proliferation Breast cancer ↓ HER2, MMP-9, Rac1; arrested cell cycle [46] ↑ p53, NOTCH1, PPARG; ↓ 𝛽-catenin [48] Gastric cancer ↓PI3K/Akt signaling pathway; ↑PTEN [50] Immunity inflammation Hepatic cancer ↑ Nrf2, PPAR𝛾, and HO-1 [ 106] Gastric cancer ↑cl-caspase3, cl-PARP, and P53↓ Akt and p-Akt [ 116] Quercetin…”